Physician profile
John D Tegtmeier
NPI 1285922625
$1,742.96
in general payments reported to CMS, 2019-2025
5 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Neuromuscular Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $128).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.31 · 2020: $35.66 · 2021: $158 · 2022: $399 · 2023: $328 · 2024: $397 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,066.29 | 2022-2025 | Botox |
| Allergan, INC. | $339.40 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $261.90 | 2021-2025 | Dysport |
| Averitas Pharma INC. | $55.24 | 2023-2024 | Qutenza |
| Boston Scientific Corporation | $20.13 | 2023 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tegtmeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.